These include those focused libraries of small-molecule compounds with their specific applications (Antibiotics Library, CNS-Penetrant Compound Library, DNA Damage & Repair Compound Library, Neural Regeneration Compound Library, PPI Inhibitors Library, etc.).
| カタログ番号 | 製品名 | ||
|---|---|---|---|
| L5500 | Toxic Compound Library | A unique collection of 277 toxic substances for high throughput screening (HTS) and high content screening (HCS); | 277 compounds |
| L1380 | Transcription Factor-Targeted Compound Library | Well-chosen 704 compounds with unique structures targeting transcription factor; | 704 compounds |
| L3500 | Histone Modification Compound Library | A unique collection of 362 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS); | 362 compounds |
| L2500 | Human Endogenous Metabolite Library | A unique collection of 1400 endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening; | 1400 compounds |
| L5900 | CNS-Penetrant Compound Library | A unique collection of 516 CNS-Penetrant compounds for high throughput screening (HTS) and high content screening (HCS); | 516 compounds |
| L9400 | PPI Inhibitor Library | A unique collection of 260 PPI-related compounds for drug screening; | 260 compounds |
| L1720 | Nucleotide Compound Library | A unique collection of 337 nucleoside and nucleotide analogues, can be used for research and development of anti-viral, anti-tumor, anti-fungal, and anti-depressive drugs; | 337 compounds |
| L7500 | Coagulation and Anticoagulation Compound Library | A unique collection of 154 procoagulation and anticoagulation related compounds for high throughput screening (HTS) and high content screening (HCS); | 154 compounds |
| L9411 | Cysteine Covalent Library | The cysteine covalent library contains 72 compounds. | 72 compounds |
| L9610 | Cyclic Peptide Library | 58 species of cyclic peptide molecules for high-throughput and high-content screening; | 58 compounds |
| L5510 | Drug-induced Liver Injury (DILI) Compound Library | A unique collection of 1040 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening； | 1040 compounds |
| L9600 | Peptide Compound Library | 533 peptides can be used in peptide drug development and signaling transduction and mechanism study; | 533 compounds |
| L7900 | Osteogenesis Compound Library | A unique collection of 320 osteogenesis related compounds for high throughput and high content screening; | 320 compounds |
| L3100 | Hematopoietic Toxicity Compound Library | A unique collection of 104 compounds with defined hematopoietic toxicity for high throughput and high content drug screening; | 104 compounds |
| L5100 | Fluorochemical Library | A unique collection of 583 fluorochemicals that can be used for high through-put screening (HTS) and high content screening (HCS); | 583 compounds |
| L9300 | Macrocyclic Compound Library | 155 macrocyclic compounds of known activity for high-throughput, high-content screening; | 155 compounds |
| L2520 | Glycometabolism Compound Library | 708 glycometabolism-related comounds, can be used for HTS and HCT; | 708 compounds |
| L2530 | Mouse Metabolite Compound Library | A unique collection of 224 mouse metabolites, which can be used for HTS and HCS; | 224 compounds |
| L7000 | Bioactive Lipid Compound Library | A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl/geranylgeranyl derivates, HETEs deHETEs, hepoxilins, Polyunsa | 385 compounds |
| L3980 | DNA Damage and Repair Compound Library Plus | Well-chosen 667 compounds with unique structures targeting DNA damage & repair; | 667 compounds |
| L2550 | Glutamine Metabolism Compound Library | A unique collection of 580 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and cancer; | 580 compounds |
| L5800 | Drug Metabolite/Impurity Library | A unique collection of 200 drug isomers/metabolites for high throughput screening (HTS) and high content screening (HCS); | 200 compounds |
| L4900 | Cardiotoxicity Compound Library | A unique collection of 127 cardiotoxicity inducing compounds for toxicological study; | 127 compounds |
| L8300 | Chromatin Modification Compound Library | A unique collection of 256 compounds targeting chromatin remodeling pathway for high throughput screening (HTS) and high content screening (HCS); | 256 compounds |
| L9410 | Covalent Inhibitor Library | A unique collection of 941 covalent Inhibitors and other molecules with common warheads like chloroacetyl，2-Chloropropionyl，Acryloyl，sulfonyl fluoride, alkyne，acrylamide, ketocarbonyl，disulfide bond, etc. | 941 compounds |
| L2510 | Lipid Metabolism Compound Library | A unique collection of 496 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS). | 496 compounds |
| L8200 | Anti-Aging Compound Library | A unique collection of 3324 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS); | 3324 compounds |
| L8000 | Stem Cell Differentiation Compound Library | A unique collection of 1213 stem cell differentiation signaling targeted compounds for high throughput and high content screening; | 1213 compounds |
| L7700 | Neural Regeneration Compound Library | A unique collection of 149 neuroregeneration related compounds for high throughput and high content screening; | 529 compounds |
| L4400 | Antibiotics Library | A unique collection of 708 compounds with antibiotic activity for new antibacterial drug screening; | 708 compounds |
| L2540 | Gut Microbial Metabolite Library | A unique collection of 352 gut microbial metabolites which can be used for HTS and HCS; | 352 compounds |
| L9500 | Target-Focused Phenotypic Screening Library | A unique collection of 1832 annotated bioactive compounds with clear targets, suitable for phenotypic screening； | 1832 compounds |
| L9820 | Beta-Lactam Compound Library | A unique collection of 105 beta-lactam compounds, can be used in HTS and HCS; | 105 compounds |
| L2900 | Oxidation-Reduction Compound Library | 1279 small molecule compounds with pro-oxidant or anti-oxidant activity for high-throughput and high-content screening. | 1279 compounds |
| L2400 | Endocrinology-Hormone Compound Library | A unique collection of 813 compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs; | 813 compounds |
